Search
for
Sort by
Research 541–570 of 1000+
- Two cases of low-prostate-specific antigen localized prostate cancer incidentally detected by computed tomography
- Efeitos do uso da finasterida sobre o volume prostático e dosagem sérica do PSA em pacientes jovens
- Re: Effect of Testosterone Supplementation With and Without a Dual 5α-Reductase Inhibitor on Fat-Free Mass in Men with Suppressed Testosterone Production: A Randomized Controlled Trial
- Crystal Structure and Synthesis of 17α-Acetoxy-pregn-4,6-diene-3,20-dione
- Urological Oncology: Testis Cancer and Advances in Oncological Therapy
- Prostate cancer and androgenic alopecia: The role of finasteride as a dual agent
- Association of Androgenetic Alopecia with Benign Prostatic Hyperplasia: A Case Control Study
- Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor
- Selenium or No Selenium- That Is the Question in Tumor Patients: A New Controversy
- Herbs for Benign Prostatic Hyperplasia
- 25 years of ERβ: a personal journey
- Male pattern baldness and incidence of prostate cancer
- Post-finasteride syndrome – does it really exist?
- Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis
- Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines
- Features of hyperandrogenism in men
- Role of serum androgens and prostate-specific antigen levels in men with androgenetic alopecia
- Finasteride in Androgenic Alopecia
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Should Male Pattern Baldness Be Considered in Prostate Cancer Risk Assessment? A Systematic Review and Meta-analysis
- Androgenetic Alopecia and Risks of Overall and Aggressive Prostate Cancer: An Updated Systematic Review and Meta-Analysis
- Chapter 6. Darwinian Health and Other Contradictions
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- Factors Driving Unique Urination Phenotypes of Male and Female 9-week-old C57BL/6J Mice
- ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Pharmacology of antiandrogens
- Differential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER